CONMED Corporation Announces Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CONMED (CNMD) PT Raised to $83 at Needham & Company
August 2, 2018 6:43 AM EDTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $83.00 (from $73.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "CNMD's 2Q18 revenue and EPS beat consensus and management raised its 2018 revenue and maintained its EPS guidance. Revenue growth improved... More
Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook
August 1, 2018 4:14 PM EDTConmed (NASDAQ: CNMD) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the quarter came in at $212.8 million versus the consensus estimate of $207.12 million.
GUIDANCE:
Conmed sees FY2018 EPS of $2.15-$2.20, versus the consensus of $2.17.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More